Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

v3.19.2
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Income Statement [Abstract]        
Revenue   $ 185 $ 37 $ 376
Operating expenses:        
Research and development $ (24,439) (13,725) (41,826) (24,604)
General and administrative (2,939) (1,886) (6,055) (3,401)
Total operating expenses (27,378) (15,611) (47,881) (28,005)
Operating loss (27,378) (15,426) (47,844) (27,629)
Interest (expense) / income, net (135) (76) (239) 9
Other income / (expense), net 32 (177) 156 (116)
Total other expense (103) (253) (83) (107)
Loss before income taxes (27,481) (15,679) (47,927) (27,736)
Income tax expense (157) (68) (291) (157)
Net loss and comprehensive loss (27,638) (15,747) (48,218) (27,893)
Net loss attributable to ordinary shareholders $ (27,638) $ (15,747) $ (48,218) $ (27,893)
Net loss per share attributable to ordinary shareholders – basic and diluted $ (1.93) $ (2.22) $ (3.37) $ (6.72)
Weighted average ordinary shares outstanding – basic and diluted 14,340,231 7,085,655 14,316,497 4,148,535